Skip to content

Knee Neuromuscular Assessment in Children With Cerebral Palsy

Reliability and Feasibility of Knee Traction Dynamometry and Electromyography Assessment in Children With Cerebral Palsy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06667518
Enrollment
20
Registered
2024-10-31
Start date
2024-09-20
Completion date
2025-03-01
Last updated
2025-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Children, Electromyography, Force Measurement, Lower Limb

Keywords

dynamometry, electromyography, cerebral palsy, child, lower limb

Brief summary

The purpose of this study is to evaluate the reliability (intra-rater and inter-rater) of the K-Pull dynamometer and the K-Myo non-invasive electromyography sensor (assessing neuromuscular activity) in the evaluation of the lower limbs in children with cerebral palsy. Specific objectives include: * Examining differences in neuromuscular activity among children with CP classified at functional levels I to III on the GMFCS scale. * Deriving conclusions from the correlation between electromyographic activity, muscle tone, and generated muscle strength. * Assessing the applicability of neuromuscular activity assessment devices in clinical settings.

Interventions

DEVICENeuromuscular Activity Assessment

K-Pull dynamometer is an assessment tool used to quantify muscle strength. It uses traction through a non-elastic strap to facilitate isometric contractions. K-Myo (non-invasive EMG sensor) is an assessment tool used to detect muscle activation and tracking patient's improvement.

Sponsors

University of Thessaly
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
5 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* children with spastic type cerebral palsy (CP), * aged between 5 and 16 years, * classified at GMFCS levels I to III, * voluntary motor control, * ambulatory, with or without the use of mobility aids, * can understand and execute verbal commands.

Exclusion criteria

* have previously undergone interventions that affect neuromuscular performance (such as surgery or botulinum toxin injections) * have sustained an injury, * demonstrate a low level of compliance.

Design outcomes

Primary

MeasureTime frameDescription
Muscle StrengthThrough study completion, an average of 5 monthsAverage Peak Force refers to the average highest force output recorded during isometric contractions and represents the maximal strength generated by the muscle group being assessed (e.g., hip or knee flexors and extensors). Unit of Measure: Newton (N)
Average Muscle ActivationThrough study completion, an average of 5 monthsAverage activation in the context of surface electromyography refers to the mean level of electrical activity detected from muscle fibers over a specific period. Unit of Measure: millivolt (mV)

Secondary

MeasureTime frameDescription
Muscle ToneThrough study completion, an average of 5 monthsEvaluated using the Modified Ashworth Scale. Unit of Measure: Scoring Options (0-4) // (higher scores - worse outcome)

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026